Recombinant Human IL-21 (carrier-free)
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0466319
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $152.60
About this award
The University of Virginia awarded contract A207_PO-0466319 to BioLegend Inc. on August 6, 2026, for the procurement of specialized biological research materials. The primary deliverable under this contract is Recombinant Human Interleukin-21 (carrier-free), a recombinant cytokine product commonly utilized in immunological and cellular research applications. The contract specifies a quantity of one unit, with delivery directed to Patrick Dowhan at the University of Virginia.
The total contract value is $152.60, reflecting a unit price of $152.60 for the single line item. No contract term or period of performance dates are specified in the award documentation. This procurement was issued by the University of Virginia, a state institution located in Virginia, and represents a routine purchase order for laboratory research materials essential to the University's research operations.
Line items
| Item | Total |
|---|---|
| Recombinant Human IL-21 (carrier-free) | $152.60 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0466319?
Contract A207_PO-0466319 was awarded to BIOLEGEND INC. by University of Virginia on August 6, 2026.
How much is contract A207_PO-0466319 worth?
Its cumulative value is $152.60.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award